SQZ Biotechnologies Company SQZ

$ 0.44 57.95%

Quarterly report 2023-Q3
added 11-08-2023

SQZ Biotechnologies Company Balance Sheet 2011-2024 | SQZ

Annual Balance Sheet SQZ Biotechnologies Company

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-36.2 M	-73.8 M	-123 M	3.08 M	-59.6 M	-	-	-	-	-	-	-
Long Term Debt	20.9 M	59.8 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	6.56 M	9.94 M	8.21 M	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	58.7 M	188 M	138 M	-	-	-	-	-	-	-
Total Current Liabilities	21.8 M	33.2 M	45.2 M	-	-	-	-	-	-	-	-	-
Total Liabilities	42.8 M	102 M	104 M	226 M	159 M	-	-	-	-	-	-	-
Deferred Revenue	715 K	12.5 M	25.9 M	19 M	16.5 M	-	-	-	-	-	-	-
Retained Earnings	-275 M	-196 M	-127 M	-76.2 M	-44 M	-	-	-	-	-	-	-
Total Assets	99.9 M	226 M	231 M	152 M	116 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	63.7 M	144 M	170 M	41.6 M	-	-	-	-	-	-	-	-
Book Value	57.1 M	124 M	127 M	-73.5 M	-43.5 M	-	-	-	-	-	-	-
Total Shareholders Equity	57.1 M	124 M	127 M	-73.5 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet SQZ Biotechnologies Company

	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	19.1 M	19.7 M	20.3 M	20.9 M	51.8 M	-	57.2 M	59.8 M	62.4 M	32.6 M	36.4 M	38.9 M	38.9 M	38.9 M	38.9 M	32.9 M	32.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	27.9 M	29.6 M	33 M	42.8 M	86.3 M	-	95.9 M	102 M	111 M	85.8 M	93.6 M	104 M	104 M	104 M	104 M	93.8 M	93.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	500 K	678 K	715 K	3.5 M	-	9.64 M	12.5 M	21.9 M	26.6 M	25.5 M	25.9 M	25.9 M	25.9 M	25.9 M	19 M	19 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-333 M	-309 M	-293 M	-275 M	-261 M	-	-217 M	-196 M	-184 M	-161 M	-142 M	-127 M	-127 M	-127 M	-127 M	-76.2 M	-76.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	29.8 M	54.1 M	73.2 M	99.9 M	155 M	-	201 M	226 M	244 M	239 M	263 M	231 M	231 M	231 M	231 M	152 M	152 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	10.2 M	24.7 M	39.9 M	63.7 M	86.5 M	108 M	125 M	144 M	167 M	185 M	205 M	170 M	170 M	170 M	170 M	39.3 M	39.3 M	-	-	61.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	1.88 M	24.5 M	40.2 M	57.1 M	68.6 M	-	105 M	124 M	133 M	153 M	169 M	127 M	127 M	127 M	127 M	58.6 M	58.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	1.88 M	24.5 M	40.2 M	57.1 M	68.6 M	88.2 M	105 M	124 M	133 M	153 M	169 M	127 M	127 M	127 M	127 M	-73.5 M	-73.5 M	-56.5 M	-	-43.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency